VOR
Vor Biopharma Inc.
$16.94
+5.35%
2026-05-08
About Vor Biopharma Inc.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Key Fundamentals
Forward P/E
-4.31
EPS (TTM)
$-70.50
Profit Margin
0.0%
Beta
1.75
Market Cap
$871.8M
Avg Volume (10D)
724K
Recent Breakout Signals
No recent breakout signals detected for VOR.
Recent Price Range (60 Days)
60D High
$19.69
60D Low
$11.70
Avg Volume
978K
Latest Close
$16.94
Get breakout alerts for VOR
Sign up for Breakout Scanner to receive daily notifications when VOR triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Vor Biopharma Inc. (VOR) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors VOR daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. VOR operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.